Imunon, Inc. — Director's Dealing 2012

Feb 24, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2012-02-22

Reporting Person: Borys Nicholas (CMO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-02-22	Option to purchase Celsion Corporation Common Stock	$2.06	A	13750	Acquired	2022-02-22	Celsion Corporation Common Stock (13750)	Direct

Footnotes

F1: The options vest in thirds over three years on the anniversary date of the option grant